**Core Concept**
Tumor-induced hypoglycemia is a rare but serious condition caused by the production of insulin-like growth factors (IGFs) or insulin itself by certain tumor types. This phenomenon is often associated with mesenchymal tumors that produce IGF-1, leading to hypoglycemia.

**Why the Correct Answer is Right**
Lymphoma is generally not associated with tumor-induced hypoglycemia. In contrast, mesenchymal tumors such as hepatocellular carcinoma and adrenal carcinoma can produce IGF-1, leading to hypoglycemia. This is because these tumors have the ability to produce and secrete IGF-1, a potent insulin-like growth factor that can lower blood glucose levels. Hepatocellular carcinoma and adrenal carcinoma are known to cause hypoglycemia through this mechanism.

**Why Each Wrong Option is Incorrect**
**Option A:** Mesenchymal tumors are indeed associated with tumor-induced hypoglycemia, particularly those that produce IGF-1. Hepatocellular carcinoma and adrenal carcinoma are examples of mesenchymal tumors that can cause hypoglycemia.

**Option B:** Hepatocellular carcinoma is a type of mesenchymal tumor that can produce IGF-1, leading to hypoglycemia. Therefore, it is not the correct answer.

**Option C:** Adrenal carcinoma is also a type of mesenchymal tumor that can produce IGF-1 and cause hypoglycemia. This makes it an incorrect option.

**Clinical Pearl / High-Yield Fact**
When evaluating a patient with hypoglycemia, it is essential to consider the possibility of tumor-induced hypoglycemia, particularly in patients with mesenchymal tumors. A high index of suspicion and thorough investigation, including imaging studies and tumor markers, are necessary to diagnose this condition.

**Correct Answer:**
✓ Correct Answer: D. Lymphoma